Open access · CC-BY
via OpenAlex
Targeting mesenchymal stem cell therapy for severe pneumonia patients
Guy Lam, Yuan Zhou, Jiaxian Wang, Yat-Ping Tsui
World Journal of Stem Cells · 2021 · ▲ 7 citations
Abstract
Pneumonia is the inflammation of the lungs and it is the world's leading cause of death for children under 5 years of age. The latest coronavirus disease 2019 (COVID-19) virus is a prominent culprit to severe pneumonia. With the pandemic running rampant for the past year, more than 1590000 deaths has occurred worldwide up to December 2020 and are substantially attributable to severe pneumonia and induced cytokine storm. Effective therapeutic approaches in addition to the vaccines and drugs under development are hence greatly sought after. Therapies harnessing stem cells and their derivatives have been established by basic research for their versatile capacity to specifically inhibit inflammation due to pneumonia and prevent alveolar/pulmonary fibrosis while enhancing antibacterial/antiviral immunity, thus significantly alleviating the severe clinical conditions of pneumonia. In recent clinical trials, mesenchymal stem cells have shown effectiveness in reducing COVID-19-associated pneumonia morbidity and mortality; positioning these cells as worthy candidates for combating one of the greatest challenges of our time and shedding light on their prospects as a next-generation therapy to counter future challenges.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4252/wjsc.v13.i2.139
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Lam, G., Zhou, Y., Wang, J., & Tsui, Y. (2021). Targeting mesenchymal stem cell therapy for severe pneumonia patients. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.v13.i2.139
Vancouver
Lam G, Zhou Y, Wang J, Tsui Y. Targeting mesenchymal stem cell therapy for severe pneumonia patients. World Journal of Stem Cells. 2021. doi:10.4252/wjsc.v13.i2.139.
BibTeX
@article{guy2021Target,
title = {Targeting mesenchymal stem cell therapy for severe pneumonia patients},
author = {Guy Lam and Yuan Zhou and Jiaxian Wang and Yat-Ping Tsui},
journal = {World Journal of Stem Cells},
year = {2021},
doi = {10.4252/wjsc.v13.i2.139},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cells International 2016
Open access · CC-BY
Umbilical Cord as Prospective Source for Mesenchymal Stem Cell‐Based Therapy
PLoS ONE 2010
Open access · CC-BY
Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null Mice
2021
Preprint · OA
The study of stem cells in cardiac surgery
Frontiers in pharmacology 2026
Open access · OA
A narrative review of stem cell-based therapy for fibrosing interstitial lung diseases: clinical evidence and translational perspectives.
Aging and Disease 2020
Open access · CC-BY
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Journal of Transplantation & Stem Cell Biology 2016
Open access · CC-BY